Spotlight on Rasagiline in Parkinson's Disease

By Oldfield Vicki   Keating Gillian M.   Perry Caroline M.  

CNS Drugs, Vol. 22, Iss. 1, 2008-01 ,pp. : 83-86

Adis International

Access to resources Recommend Favorite

Comparison of the Risk of Adverse Events with Pramipexole and Ropinirole in Patients with Parkinson’s Disease: A Meta-Analysis

By Etminan M.  

Drug Safety, Vol. 26, Iss. 6, 2003-01 ,pp. : 439-444

Adis International

Access to resources Recommend Favorite

Safety of rasagiline for the treatment of Parkinson's disease

By Perez-Lloret Santiago   Rascol Olivier  

Expert Opinion on Drug Safety, Vol. 10, Iss. 4, 2011-07 ,pp. : 633-643

Informa Healthcare

Access to resources Recommend Favorite

Tolerability and Safety of Ropinirole versus Other Dopamine Agonists and Levodopa in the Treatment of Parkinson's Disease: Meta-Analysis of Randomized Controlled Trials

By Kulisevsky Jaime   Pagonabarraga Javier  

Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. : 147-161

Adis International

Access to resources Recommend Favorite

Treatment of depression in Parkinson's disease: a meta-analysis

By Verhey F.R.J.   Havermans A.G.M.   Klaassen T.   van Praag H.M.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 246-246

Elsevier

Access to resources Recommend Favorite